AKTOCYTE: A Revolutionary Nutraceutical for Cancer Care
Recently, scientists from the Department of Atomic Energy and M/s. IDRS Labs Pvt. Ltd., Bengaluru, have developed AKTOCYTE tablets, aiming to enhance the quality of life for cancer patients undergoing radiotherapy.
- AKTOCYTE tablets demonstrate exceptional efficacy in pelvic cancer patients undergoing radiotherapy, leading to significant recovery and eliminating the need for surgical interventions.
- Positioned as an adjuvant to cancer radiotherapy, a regenerative nutraceutical, an immunomodulator, and an antioxidant, AKTOCYTE showcases versatility in addressing various aspects of cancer care.
- AKTOCYTE received approval from the Food Safety and Standards Authority of India (FSSAI), emphasizing its safety and compliance with quality standards, providing confidence to healthcare ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 SEBI Norms for Finfluencers
- 2 Vibrant Villages Programme-II
- 3 Balancing National Security and Human Rights: The Rohingya Issue
- 4 PRAHAAR – National Counter-Terrorism Policy
- 5 AI Governance Framework & IndiaAI Mission
- 6 LWE Strategy – “Legacy & Thrust Areas”
- 7 e-Courts Mission Mode Project Phase III
- 8 National Urban Digital Mission (NUDM)
- 9 51st G7 Summit 2025
- 10 The SHANTI Act, 2025
Current Affairs
- 1 Rights of Non-Tribals in Scheduled Areas
- 2 Judicial Recusal
- 3 Data Governance Quality Index (DGQI)
- 4 Article 355
- 5 Governor's Power to Dismiss the Ministers
- 6 Commission of Railway Safety
- 7 Right to Change Name
- 8 Prevention of Damage to Public Property
- 9 Jan Vishwas (Amendment of Provisions) Act 2023
- 10 Rule 176 vs. Rule 267 of Rajya Sabha
